Trial
NCT02920190
Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
—
Condition
Monoclonal Gammopathies
Intervention
Liraglutide
Why stopped
Lack of funds to cover the costs of the study medications
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-09-21